Bevacizumab Plus Capecitabine Benefits in Elderly mCRCBevacizumab Plus Capecitabine Benefits in Elderly mCRC

Elderly patients with metastatic colorectal cancer (mCRC) benefit from combining bevacizumab with capecitabine. Is this a new standard of care? Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news